Histamine Deficiency Decreases Atherosclerosis and Inflammatory Response in Apolipoprotein E Knockout Mice Independently of Serum Cholesterol Level

作者：Wang Ke Yong; Tanimoto Akihide; Guo Xin; Yamada Sohsuke; Shimajiri Shohei; Murata Yoshitaka; Ding Yan; Tsutsui Masato; Kato Seiya; Watanabe Teruo; Ohtsu Hiroshi; Hirano Ken Ichi; Kohno Kimitoshi; Sasaguri Yasuyuki^*

来源：Arteriosclerosis, Thrombosis, and Vascular Biology, 2011, 31(4): 800-U188.

DOI：10.1161/ATVBAHA.110.215228

• histamine
• histidine decarboxylase
• hyperlipidemia-induced atherosclerosis
• inflammation
• matrix metalloproteinase

Objective-Histamine and histamine receptors are found in atherosclerotic lesions, and their signaling and subsequent proatherogenic or proinflammatory gene expression are involved in atherogenesis. In the present study, we generated apolipoprotein E (apoE) and histamine synthesizing histidine decarboxylase double knockout (DKO) mice on a C57BL/6J (wild-type mice) background to clarify the roles of histamine in atherosclerosis.
Methods and Results-Wild-type, apoE knockout (KO), and DKO mice were fed a high-cholesterol diet to analyze hyperlipidemia-induced atherosclerosis. Compared with wild-type mice, apoE-KO mice showed increased expression of histamine and its receptors, corresponding to increased atherosclerotic lesion areas and expression of inflammatory regulators, such as nuclear factor-kappa B, scavenger receptors, inflammatory cytokines, and matrix metalloproteinases. Histamine deficiency after deletion of histidine decarboxylase reduced atherosclerotic areas and expression of a range of the inflammation regulatory genes, but serum cholesterol levels of DKO mice were higher than those of apoE-KO mice.
Conclusion-These results indicate that histamine is involved in the development of atherosclerosis in apoE-KO mice by regulating gene expression of inflammatory modulators, an action that appears to be independent of serum cholesterol levels. In addition to acute inflammatory response, histamine participates in chronic inflammation, such as hyperlipidemia-induced atherosclerosis, and might be a novel therapeutic target for the treatment of atherosclerosis. (Arterioscler Thromb Vasc Biol. 2011;31:800-807.)

• 出版日期2011-4